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ABSTRACT 
 
Background 
Oral candidiasis is the most common infection of the oral mucosa of HIV-seropositive 
patients, although its frequency is rapidly decreasing with the advent of highly active 
antiretroviral therapy (HAART).  Many questions regarding its complex pathogenesis remain 
unanswered.  The diagnosis is usually established with non-invasive techniques such as 
mucosal smears.  Oral lesions of HIV-associated Kaposi sarcoma (HIV-KS) are routinely 
biopsied and frequently show secondary infection with Candida albicans or other Candida 
species.  
 
Aims and objectives 
The aim of this investigation was to determine the frequency and histomorphology of 
secondary Candidal infection of the surface epithelium of oral HIV-associated KS lesions 
(HIV-KS), which are routinely biopsied in HIV infected patients. 
 
Materials and methods 
Haematoxylin and eosin (HE), and Periodic Acid-Schiff (PAS) stains of 133 cases of oral 
Kaposi sarcoma diagnosed between the period 2003 and 2007 within the Division of Oral 
Pathology were examined histologically for intensity and morphology of Candidal 
colonisation, depth of invasion, number of organisms, epithelial reactions and associated 
inflammatory response.  The depth of Candidal invasion and severity of infection were 
correlated with the available CD4 T cell counts of HIV seropositive patients at the time of 
biopsy.   
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Results 
Almost forty one percent (40.62%) of all oral HIV-KS cases were secondarily infected with 
Candida species.  The intensity varied from an isolated single pseudohyphus to matted 
colonies of vegetative yeasts and psuedohyphae. Whilst in most cases the organisms did not 
invade beyond the parakeratin layer, pseudohyphae were noted extending into the stratum 
spinosum in 2 cases, and a single case showed a pseudohyphus within the lamina propria.  A 
further 2 cases showed pseudohyphae growing in the pyogenic membrane.  Neutrophilic 
permeation of the epithelium and Munro micro-abscess formation, features commonly 
associated with Candidal infection, were frequently present even in the absence of Candidal 
infection.  Candidal organisms were often present in the absence of inflammation.   
 
Conclusion 
Oral lesions of HIV-KS are commonly secondarily infected with large numbers of Candidal 
organisms.  The morphological characteristics of secondary Candidal infection within the 
surface epithelium of HIV-KS lesions suggest an altered pathogenetic pathway.  Further 
studies are necessary in this regard. 
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CHAPTER 1 
 
1.0 INTRODUCTION 
 
Our understanding of the epidemiology and pathology of human immunodeficiency virus 
(HIV) related oral disease has undergone significant change since the first description of oral 
lesions in HIV positive patients in 1982.1  Since then it has been conclusively shown that oral 
lesions in HIV disease: 
a. may present in individuals soon after sero-conversion as part of the acute infection 
syndrome2 
b. may be indicative of the presence of HIV disease3 
c. may predict progression of HIV disease4 
d. can be related to a decline in CD4 counts and rising viral load3,5 
e. can be used as indicators for initiation of anti HIV and anti-opportunistic infection 
prophylaxis and therapy in countries with poor resources while CD4 T cell counts 
are essential to monitor the response to treatment.3,6 
f. are used in staging systems such as the World Health Organisation (WHO) clinical 
staging system3 
g. may be indicative of successful highly active antiretroviral therapy (HAART) 
therapy, or the first sign of failure of such therapy,7 or the emergence of the immune 
reconstitution inflammatory syndrome (IRIS)8 
 
One of the most frequent oral lesions in HIV disease is candidiasis.3  The pathogenesis of 
Candida infection is complex and although progress has been made in elucidating the factors 
affecting Candidal infection many questions remain unanswered.  The surface epithelium in 
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oral lesions of HIV-KS frequently shows secondary infection by C. albicans with varying 
degrees of tissue invasion.  The pathogenesis of such opportunistic fungal infections probably 
differs between oral lesions of HIV-KS, other examples of HIV related oral disease or even 
infection of normal oral mucosae in HIV seropositive patients.  Such differences in 
pathogenetic pathways may manifest histologically as variations in the frequency or intensity 
of the infection or in the histomorphology of the tissue reactions.  In order to investigate this 
hypothesis we decided to undertake a study designed to determine the histological variables 
in oral lesions of HIV-KS. 
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CHAPTER 2 
 
2.0 LITERATURE REVIEW 
 
2.1 Introduction 
An extensive review of the literature reveals a paucity of published material regarding 
Candidal secondary infection of oral HIV-KS lesions.  The literature on HIV-KS and oral 
Candida infection per se is extensive, including several reviews and studies on the essential 
role of Human Herpes Virus 8 (HHV8) in the development of KS, the development of KS in 
HIV-seropositive patients and Candida infection in immunocompromised patients.5,9,10 
 
2.2 Kaposi sarcoma 
KS is a multifocal angioproliferative neoplasm characterised by inflammation, oedema,  
neoangiogenesis and spindle cell proliferation.  The pathogenesis of HIV-associated KS 
(HIV-KS) is multifactorial.  KS is a tumour of lymphatic endothelial origin that primarily 
affects mucocutaneous sites, but may also involve internal organs.10  Five clinical 
presentations of KS are recognised and these include the classic, endemic (African), 
iatrogenic, immuno-suppression associated and HIV associated variants.11 
 
2.2.1 Incidence of HIV-associated KS (HIV-KS)  
HIV-KS is the most frequent oral neoplasm and the fourth most common dermatological 
neoplasm found in HIV-seropositive individuals and may occur at any level of CD4 T cell 
count during HIV infection, but usually affects HIV seropositive subjects with CD4 T cell 
counts of below 200 cells/µl.12  According to Sitas et al.13 KS was endemic in black South 
Africans even before the advent of HIV and the incidence has since risen threefold between 
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1988 and 1996 and continues to increase as the HIV pandemic grows.13   Whilst they state 
that KS represents about 9% of all cancers in men in Sub-Saharan Africa, the authors do not 
comment on the exact prevalence of KS in South Africa.13  According to the South African 
National Cancer Registry (1992-1996) the incidence of KS has doubled in men and has 
increased about seven-fold in women.13  Thus the M:F ratio declined from 7:1 in 1988 to 2:1 
in 2001.13  Somdyala et al.14 report that the incidence of Kaposi sarcoma was reported to be 
higher for males (1.6 per 100 000) than females (0.3 per 100 000).  
 
2.2.2 Aetiopathogenesis  
Human Herpes Virus 8 (HHV8) infection has been identified as the cause of KS in HIV- 
seropositive individuals.10   HHV8 is a gamma-2 herpes virus and as with all herpes viruses, 
can exist in either a latent or a lytic state.15   
 
Although HHV8 infection in HIV-seropositive individuals is common in Botswana and 
Gambia, with seroprevalence rates of 76–87% and 29–84% respectively, KS was rare in these 
areas prior to the HIV epidemic.11  Only a single case of KS was documented in a population 
of approximately 45 000 Ethiopians living in Israel with an HHV8 seroprevalence rate of 39–
57%,  between 1982 and 1998.9 
 
The seroprevalence of HHV8 has been reported to increase with age and is similar in men 
and women.9  It is also found to decrease with increasing levels of education and is lower in 
whites than in blacks suggesting that poverty may be an important determinant in 
transmission.13  The risk of KS increases with increasing antibody titres to HHV8 but for a 
given titre the risk is greater in HIV-seropositive compared with HIV-seronegative 
individuals.13     
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HHV8 infection alone is not sufficient however to initiate KS development.  Many factors 
such as HIV tat protein, immune suppression and dysregulation of cytokines, a local 
inflammatory environment, HHV8 associated oncogenesis, angiogenesis, growth factors and 
adhesion molecule functions cooperate with HHV8 to drive the initiation and promotion of 
HIV-KS.10 
 
Latent virus predominates in KS lesions, with a low percentage of cells exhibiting lytic 
replication.15  Cell types identified as supporting lytic and/or latent gene expression include 
monocytes, endothelial/spindle cells of KS lesions, B cells, and epithelial cells.15  It has been 
postulated that most HIV-KS lesions are monoclonal in origin, however it is not clear if HIV-
KS is a monoclonal angioproliferative disorder or a malignant neoplasm.10 
 
Sexual transmission of HHV8 may explain why KS is most common in homosexual and 
bisexual men especially those with a history of insertive oral and anal sexual contacts, this 
being the highest risk factor among a spectrum of sexual practices.9,16-19  Another possible 
route of transmission of HHV8 is via saliva through non-sexual close personal  
contact.9,12,18-20  Sitas et  al.13 have documented that mother to child transmission of HHV8 is 
also possible.  In addition to HHV8 infection which dramatically increases the risk for KS,13 
the discrepancy between the geographical distribution of KS prior to and with the AIDS 
epidemic suggests the presence of an additional co-factor in the development of this 
malignancy that needs to be investigated and defined.9 
 
HIV contributes to the pathogenesis of HIV-KS through various mechanisms: HIV Tat 
protein may directly promote HHV8 replication.8  HIV-KS originates via induction of 
inflammatory T helper (Th)-1 cytokines which is associated with a marked impairment of 
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cellular immune responses brought about by HIV infection.8  Inflammatory infiltrates in 
HIV-KS lesions comprise of CD8 T cells, monocytes, macrophages and dendritic cells.8  
These cells produce inflammatory cytokines that together with HHV8 gene products may 
sometimes activate endothelial cells and trigger the development of HIV-KS.8   
 
2.2.3 Clinical features of oral HIV-KS  
HIV-KS ranges from a mild slowly progressive disease to a rapidly progressive life 
threatening condition, the prognosis of which is poor if not treated.10  HIV-KS occurs as 
single or more frequently as multiple lesions in the oral cavity either concomitantly with skin 
lesions or in isolation.11  The trunk, arms, head and neck are the most commonly affected 
sites.21  In 71% of HIV seropositive subjects with KS, the oral cavity will be affected at some 
time and is the initial site of involvement in approximately 25% of cases.21  Subjects with oral 
HIV-KS have a higher mortality rate than subjects with exclusively cutaneous 
manifestations.21 
 
Oral HIV-KS most frequently affects the hard palate, gingiva, dorsum of the tongue and in 
advanced cases the tumour may infiltrate into the underlying bone.11  Symptoms in the oral 
cavity include pain, bleeding, mobility of teeth and functional interferences.10  The lesions 
may be single or multifocal, initially presenting as macules that may progress to papulo-
nodular lesions, which may eventually become confluent to form large exophytic masses.21  
The lesions are bluish-purple or red and do not blanch with pressure.21 They may be indolent 
or locally aggressive.21  
 
HIV-KS causes significant morbidity and mortality which is usually closely related to low 
CD4 T cell counts and high HIV and HHV8 viral loads.12  However, in a series of 130 cases 
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of HIV seropositive patients with KS, only 75% of patients had CD4 T cell counts of less 
than 200/mm3.  The authors concluded that low CD4 T cell counts were not a prerequisite for 
the development of KS as 10% of patients in this series had CD4 T cell counts greater than 
500/mm.9,12,22  In advanced cases of HIV-KS, in the presence of other as yet unidentified co-
factors co-operating with HHV8 oncogenes, a subset of the benign monoclonal cells evolve 
into a malignant clone that undergoes expansion.10 
 
2.2.4 HIV infection, highly active antiretroviral therapy (HAART) and KS 
In sub-Saharan Africa, the natural course of HIV-KS in the absence of HAART is 
characterised by rapid disease progression associated with a high HHV8 burden and short life 
expectancy.23  Subjects with extensive exophytic oral lesions and tumour associated oedema 
have higher death rates than HIV seropositive subjects having exclusively cutaneous 
lesions.23  Treatment of HIV-KS is focused on control of tumour growth and palliation.  
HAART should always be instituted in HAART naive HIV-seropositive subjects with KS, 
since it promotes regression of KS lesions.23  KS may recrudesce early in HIV seropositive 
patients following the introduction of HAART, as an immune reconstitution inflammatory 
syndrome (IRIS).23  IRIS can be defined as an exuberant immune system mediated 
inflammatory response to a pre-existing subclinical pathogen or tumour antigen after 
treatment has brought about an improvement in a host with a previously profoundly 
depressed immunity.24  In HIV infected persons, HAART-induced IRIS has reportedly been 
described in relation to opportunistic infections including Herpes simplex virus, Herpes 
zoster virus, Mycobacterium tuberculosis,23 Mycobacterium avium complex and 
Cryptococcus neoformans.25  HAART-induced IRIS in HIV seropositive patients has also 
been described in relation to autoimmune thyroid disease.23  HIV-IRIS is reported to occur 
despite a reduction in HIV load and an improvement in all HIV related immunological 
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parameters after the early introduction of HAART.23  However, the exact 
immunopathogenetic mechanisms that bring about IRIS have not yet been clearly elucidated 
upon.23 
 
In HIV-seropositive subjects who start HAART at an early stage of HIV infection, the 
number and function of CD4 T cells tend to return to normal.  Subjects who start HAART 
when the HIV infection is moderately advanced (with CD4 T cell counts between 100 × 
106/L and 300 × 106/L), will not show a similar recovery.  However, even such a partial 
immune reconstitution results in a profound decline in HIV associated morbidity and 
mortality.8 
 
All HIV-immune reconstitution inflammatory syndrome (HIV-IRIS) events occur in subjects 
who display as indicators of immune reconstitution, a decrease in HIV viral load and an 
increase in CD4 T cell count.8  HIV seropositive subjects with IRIS episodes tend to be 
younger at the time of introduction of HAART and tend to have a lower median baseline 
CD4 T cell percentage than HIV seropositive subjects who do not experience IRIS.8  The 
median time to onset of IRIS is reported to be 12 weeks in patients who display this 
response.8 
 
2.2.5 Histological features of oral HIV-KS 
HIV-KS evolves through three histopathological stages viz. the patch, plaque and nodular 
stages.11  The patch stage is characterised by a proliferation of small vessels which results in 
an irregular, jagged, vascular network surrounding pre-existing vessels.11  Lesional 
endothelial cells have a bland appearance and may be associated with scattered lymphocytes 
and plasma cells.11  The plaque stage demonstrates further proliferation of these vascular 
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channels along with the development of a significant spindle cell component.11  In the 
nodular stage, the spindle cell component increases to form a nodular tumour-like mass that 
may resemble a fibrosarcoma or other spindle cell sarcomas.11  Numerous extravasated 
erythrocytes are present and slit-like vascular spaces may be discerned.11  Even though 
secondary Candidal colonisation is often seen routinely within the superficial keratinous 
layers of the surface epithelium of HIV-KS lesional tissue during routine histological 
examination, secondary Candidal colonisation is not frequently reported in general 
histological descriptions of HIV-KS.  
 
2.3 Candidal infection in HIV-seropositive patients 
2.3.1 Incidence, epidemiology and aetiology of candidiasis 
Oral candidiasis due to Candida albicans infection is the most common oral opportunistic 
infection in patients with HIV infection.26,27 C. albicans is the most common fungal pathogen 
of humans accounting for 60% of all fungal infections.28,29  Candida albicans is an imperfect 
diploid dimorphic fungal organism that normally exists as a commensal of the oral mucosa 
and the gastrointestinal tract.28,30  C. albicans consists of oval budding yeast cells in its non-
vegetative form and are 2 to 4 microns in size while in its vegetative form it consists of long 
septate pseudohyphae with large oval refractile chlamydospores at the septate junctions or 
free ends of the pseudohyphae.31 
 
Factors that may influence the carriage of Candida, include immunosuppression particularly 
HIV infection and antimycotic or antibiotic treatment.27  Several studies have shown that the 
asymptomatic carriage of oral Candida species varies geographically in healthy and 
compromised individuals.27 Reports vary in different regions of South Africa.27  The rate of 
asymptomatic carriage is reported to be higher in the Western Cape, with 68% of HIV- 
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seronegative subjects and 75% of HIV seropositive patients carrying yeasts.32  The authors 
did not however document the population group of their sample.32  Seventy per cent of the 
yeasts identified by Patel et al.27 were C. albicans and approximately 30% were non-albicans 
species in HIV-seropositive subjects.  Candida carrier rates are reported to be higher in the 
black South African population than elsewhere in Africa.27  HIV-seropositive patients carry 
more as well as a greater variety of yeasts than HIV-seronegative subjects.27 
 
The most common species of yeast isolated from patients with oral candidiasis is C. 
albicans.19  The non-albicans yeasts isolated from the oral cavity in immunocompromised 
patients include Candida glabrata, Candida krusei, Candida parapsilosis, Candida 
tropicalis, Candida guilliermondii, Candida dubliniensis and saccharomyces cerevisiae.33 
Studies have shown that non-albicans species may become pathogenic in HIV-seronegative 
and HIV-seropositive patients.27  For example, C. glabrata, C. parapsilosis, C. tropicalis and 
S. cerevisiae have been isolated from infections in neonates, secondary sepsis in bone marrow 
transplant patients, and fungaemia.27  This may change the perception of non-albicans yeasts 
from opportunistic to exogenous infective agents that can be transmitted readily from person 
to person and be easily acquired by immunocompromised people.27 
 
Several factors may contribute to the high carrier rate of Candida albicans yeasts.  The 
importance of diet was highlighted in recent studies that showed malnourished HIV- 
seropositive children in Nigeria carried more yeasts than a similar population in the United 
States,34 and from Turkey where different population and age groups with varying diets 
showed varying carriage rates.35  Patel et al.27 demonstrated in their sample of black South 
African adults, whose diet is usually high in carbohydrates, that diet enhanced the 
proliferation of Candida, its adhesion to epithelial cells and the production of acidic products. 
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Oral yeast colonisation among AIDS household contacts is reportedly high, which suggests 
that transfer and colonisation of strains can occur readily.27  This transfer may not be related 
per se to HIV status but to exposure to AIDS patients with high Candida albicans counts.27  
The HIV-seropositive and HIV-seronegative patients were from the same low socioeconomic 
densely populated area, where several families live in one house and general hygiene was 
poor.27 
 
The hallmark of HIV infection is immune suppression which Candida takes maximum 
advantage of.28  Candidiasis can also develop in patients with lymphoma, those undergoing 
steroid therapy and in transplant patients, all of whom are immunocompromised.15,28   
However, the incidence of oral candidiasis in HIV infection has been significantly reduced 
since the introduction of HAART.7   
 
2.3.2 Clinical features 
HIV-associated oral candidiasis usually affects the hard and soft palate, tongue, buccal 
mucosa and the floor of the mouth.36  It presents as erythematous patches, or creamy white 
curd-like lesions classified as the pseudomembranous type.36 
 
The pseudomembranous form of HIV-associated oral candidiasis is characterised by the 
presence of multifocal smooth white papular lesions comprising the pseudohyphae, that can 
usually be rubbed away leaving a red surface.28  The erythematous form of oral candidiasis 
typically presents as diffuse and multiple foci of macular erythema involving the palate, 
oropharynx, buccal mucosa, and dorsal tongue, but pseudohyphae are frequently absent.28  In 
HIV infection, oral candidiasis can be complicated by oropharyngeal candidiasis, which may 
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limit food consumption and lead to weight loss, threatening the general health and well-being 
of HIV infected patients.28 
 
Oral candidiasis is usually an infection with superficial levels of tissue invasion.37  The 
pseudomembranous and erythematous variants of oral candidiasis are the most common 
clinical presentations of mucosal candidiasis associated with HIV infection.36  Further clinical 
variants include angular cheilitis, exfoliative cheilitis, and Candida associated palatal 
papillary hyperplasia.36  Diagnosis of these specific forms of oral candidiasis in HIV infected 
patients is obtained by clinical diagnostic criteria.  Symptoms may include burning pain, 
altered taste sensation, and difficulty swallowing liquids and solids.28   
 
The pseudomembranous form can be easily diagnosed by demonstrating the presence of 
Candida yeasts and pseudohyphae on wet mounts or Periodic Acid Schiff (PAS) or Grocott 
stained smears of material obtained by swabbing the lesions and may further be confirmed by 
isolation of the Candida species on culture.28,36  In the erythematous form however, the 
sparse presence of Candida at the mucosal surface frequently requires a biopsy and Periodic 
Acid Schiff or Grocott staining to establish a formal diagnosis.28,36 
 
Clinically, oral candidiasis is most common in HIV-seropositive individuals when the CD4 
count drops below 200 cells/ul (lower limit).15,22,28  Blood CD4 T cell numbers were 
historically the primary prognosticator for the development of oral candidiasis.38 It has 
however  been demonstrated in a study that evaluated the predictive role of HIV viral load 
against CD4 T cell counts, that viral load is a more reliable predictor for oral candidiasis.39  It 
was also concluded that it should not be inferred that high viral load is causative for oral 
candidiasis.10,12,28,39  It is suggested that other risk factors also play a role in the direct 
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development of oral candidiasis including alcohol or drug abuse and possible high risk sexual 
behaviour.15,22,28    
 
2.3.3 Pathogenesis of Candidal infection 
The development of oral candidiasis in HIV seropositive patients is mainly due to a complex 
interplay of factors such as an altered innate immunity, altered acquired humoral and cell 
mediated host immune responses and C. albicans virulence factors.28 
 
 
 
 
 
 
 
 
 
Fig.1 Diagrammatic representation of the interplay between altered innate immunity, altered host 
immunity and Candidal virulence factors in the pathogenesis of Candidal infection in HIV- 
seropositive patients 
 
2.3.3.1      Alterations in oral innate resistance to C. albicans in HIV infection 
Saliva establishes a dynamic equilibrium between C. albicans and other oral commensal 
microbiota, preventing oral candidiasis in normal hosts with an intact immunity.28  A 
correlation was found between a 40% reduction in salivary flow rate in HIV-seropositive 
patients and enhanced recovery of Candida from the saliva of these patients.40  The 
occurrence of oral candidiasis is increased in patients with acidic saliva.41  A low pH has 
C. albicans 
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been shown to increase the adherence of C. albicans to epithelial surfaces in vitro.42  Glucose 
presence in saliva augments the growth rate of C. albicans in vitro and the resulting acidic pH 
promotes the increased activity of Candida secreted aspartyl proteinases (SAPs).28  Increased 
Candida SAPs expression enhances Candidal virulence by degrading a host substrate such as 
mucin, which plays an important role in lubrication of epithelial surfaces and host defence.28   
 
Lactoferrin, histatins, calprotectin and antileukoprotease inhibit the growth of C. albicans and 
its attachment to the oral epithelium.28 Lysozyme and lactoferrin are two major non-
immunological antimicrobial proteins in saliva which possess concentration, time and strain 
dependent fungicidal activity against C. albicans in vitro.43  The concentration of lysozyme is 
reported to be increased in HIV-seropositive patients while the anti-Candidal activity of 
saliva is decreased, the contribution of salivary lysozyme to limiting the proliferation of C. 
albicans in the oral cavity of these patients is doubtful.28  Salivary concentrations of 
lactoferrin in patients with HIV infection have been variously reported to be increased,44 
unchanged,45 or decreased.40  The predisposition to oral candidiasis in HIV-seropositive 
patients is therefore not definitively associated with a defective production of lactoferrin.28 
 
Histatins are reported to have fungicidal activity against pathogenic fungi such as Candida 
albicans, Cryptococcus neoformans and Aspergillus fumigatus, and are present in the saliva 
of healthy adults.28  The concentration of histatins in the saliva of HIV infected patients has 
been determined to be increased,44 unchanged,40 or decreased.46  These varying results may 
have been caused by the different stages of HIV infection among patients in the studies as 
well as by the analytical methods employed.28,44,40,46  Decreased concentrations of histatins 
correlate to an increased tendency for the development of oral candidiasis in HIV infected 
patients.47  This suggests that decreased histatin concentrations and/or an inability of these 
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proteins in saliva to interact with C. albicans may contribute to the defective salivary anti-
Candidal activity seen in HIV seropositive patients.28,47  
 
Calprotectin is produced by PMNs, monocytes, macrophages and mucosal keratinocytes.48  
Salivary calprotectin concentrations and oral keratinocyte expression of calprotectin are 
augmented in response to oral candidiasis, in both HIV-seropositive and HIV-seronegative 
patients.28  Salivary concentrations of calprotectin are reported to be deficient in HIV- 
seropositive patients with oral candidiasis or high salivary Candidal counts compared to 
those in HIV-seropositive patients without oral candidiasis or with low salivary Candidal 
counts.49  Diminution of calprotectin may predispose to oral candidiasis in HIV infection.28   
A study of the oral mucosa of HIV infected patients with oral candidiasis demonstrated 
Candidal pseudohyphae penetrating through the epithelial parakeratin layer but not extending 
beyond the spinous layer zone of keratinocyte calprotectin expression.50 
 
Antileukoprotease produced by keratinocytes is involved in non-immunological defence 
against C. albicans at mucosal sites.28 In addition to its inhibition of leukocyte-derived 
proteinases, antileukoprotease has fungicidal activity against C.albicans and it may thus play 
an important role in innate mucosal defence.51 Antileukoprotease also exhibits anti-HIV-1 
activity in vitro and may contribute to the antiviral activity of saliva associated with the 
infrequent oral transmission of HIV-1.51 
 
Interferon-gamma (IFN-γ) promotes expression of the glycoprotein desquamin, a cell 
adhesion molecule in the stratum corneum of the human epidermis which possesses lectin-
like properties for amino sugars, as well as trypsin-like serine proteinase and RNase 
activity.28  Desquamin thus plays a crucial role in desquamation and shedding of Candida 
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from the superficial portion of the epithelium.  In addition to these indirect mechanisms, 
keratinocytes  possess several potential antimicrobial mechanisms which may directly 
contribute to host defense against Candida: (i) oral keratinocytes express inducible nitric 
oxide synthase activity28 and NO has been associated with anti-Candidal activity and 
resistance to mucosal candidiasis;52 (ii) oral keratinocytes produce numerous antimicrobial 
peptides, including defensins 1 to 3, cathelicidins, adrenomedullin, calprotectin,50 and 
bactericidal permeability increasing protein (BPI), which as natural antibiotics contribute to 
the innate immunity of the epithelium.53   
 
Keratinocytes express on their cell membranes BPI, which is also an abundant constituent of 
polymorphonucleocytes (PMNs).53  The role of BPI in limiting C. albicans colonization or 
infection of the oral mucosa remains to be determined.53  Oral keratinocytes directly inhibit 
the growth of blastoconidia and/or pseudohyphae of Candida species in vitro, with an 
essential requirement for cell contact.54  Direct growth inhibition of Candida by oral 
keratinocytes appears to occur through a novel and distinct mechanism, complementary to 
other components of the antimicrobial armamentarium of oral keratinocytes.28  The role of 
keratinocytes in host protection against Candida at mucosal surfaces appears likely, since C. 
albicans pseudohyphae are restricted to the upper layers of the oral epithelium in candidiasis 
and are some distance away from lymphocytes and Langerhan’s cells located in deeper 
layers.28 
 
2.3.3.2      C. albicans virulence factors 
The ability of C. albicans to colonize and penetrate human oral epithelium depends on 
imbalances between Candidal virulence attributes and specific defects in host immunity.28  
C.albicans possesses a multiplicity of properties, including adhesins, dimorphism, phenotypic 
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switching, biofilm formation,  molecular mimicry of mammalian integrins and secretion of 
hydrolytic enzymes, each with a low propensity for enhancing fungal infection and none of 
these properties being necessarily dominant.28  All of the virulence attributes, even in 
combination, are unable to fully overcome intact host defences.28  An important virulence 
trait that promotes disease establishment and progression is a morphological transition from a 
yeast form to a pseudohyphal growth form which is considered to be the most invasive.55   
 
Mucosal pH regulates expression of C. albicans virulence genes PHR1 and PHR2 and is an 
important environmental signal in determining the virulence capacity of Candida and/or 
alteration of the host defences.56   
 
Hydrolytic enzymes are probable virulence factors in pathogenic Candida species.57  Among 
these, C. albicans SAPs, under the control of a multigene family (SAP1 to SAP10) expressing 
distinct isoenzymes that are regulated differentially at the mRNA level in vitro, are 
implicated in the breakdown of several host substrates.57  Phospholipase B also contributes to 
the pathogenesis of candidiasis by the degradation of host tissues.58  Candidal SAPs antigens 
have been detected on the surface of blastoconidia and pseudohyphae adhering to human oral 
mucosa.59  C. albicans isolates from HIV-seropositive patients with candidiasis not only 
exhibit enhanced adherence to buccal epithelial cells but also produce higher SAPs levels in 
vitro than do strains isolated from HIV-seronegative control groups.28 
 
HIV infected individuals, compared with healthy controls have an increased incidence of 
symptom free oral C. albicans carriage and a heightened frequency of oral candidiasis.38,60 
The reasons for this may be the heightened bio-film forming ability of Candida colonising 
the oral cavity in HIV-seropositive individuals and the compromised immune system which 
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may lead to possible alterations in the function of host mucosal cells which offer variable 
receptivity and avidity to Candida.38,39,60  In the initial adhesion phase of Candidal biofilm 
formation (adhesion phase), there are no complex structures, only a few layers of adherent 
cells in the budding-yeast phase of growth.62  With biofilm development and maturation, the 
Candidal organisms differentiate to varying degrees,63,64 comprising of complex intertwining 
layers of yeast, pseudohyphae and hyphae embedded in the extracellular matrix.65  Candidal 
biofilms have a complex architecture.66  A structural feature of Candidal biofilms is the 
presence of water channels, which are thought to develop as a result of the detachment of 
individual microcolonies from the biofilm matrix.66  Water channels permit waste disposal 
and nutrient influx into biofilms, so that even the deeply embedded yeast cells have access to 
nutrients and oxygen.39,66    
 
Furthermore, clinical and in vitro resistance to antifungal azoles frequently occurs in oral 
candidiasis when CD4 T cell counts fall to <200 cells/mm3, either by selection or acquisition 
of resistant strains of Candida albicans or by infection with inherently resistant species of 
Candida other than C. albicans.28  The full potential impact of antiretroviral therapy on the 
ability to reconstitute immunity and therefore to reduce the incidence of oral candidiasis and 
oesophageal candidiasis has been hampered by suboptimal adherence, toxicity, and resistance 
to antiretrovirals, as well as the limited availability of these treatments in developing 
countries where most HIV infected patients reside.28 
 
2.3.3.3 Altered mucosal immunity against C. albicans in HIV infected patients 
2.3.3.3.1 Humoral immune response 
Analysis of Candida specific antibodies in the saliva of HIV-seropositive patients reveal that 
despite changes in total immunoglobulin levels, when levels of Candida specific antibodies 
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are normalized to total protein or total immunoglobulin levels of the corresponding isotype, 
no distinct differences in IgA or sIgA are seen, regardless of CD4 T cell count.28  De 
Repentigny et al.28 concluded that there is no evidence of appreciable changes in levels of 
Candida specific IgA in saliva that would account for the prevalence of candidiasis among 
HIV-seropositive patients. 
 
2.3.3.3.2 Cellular immune response 
HIV infection of oral mucosal cells is central to the pathogenesis of oral mucosal candidiasis 
in HIV-seropositive patients.67  Because oral epithelial keratinocytes from HIV infected 
patients contain integrated HIV proviral DNA and HIV Tat/Rev RNA, possibly acquired 
through contact with submucosal HIV positive lymphocytes and/or Langerhan’s cells, the 
anti-Candidal properties of these cells could be potentially impaired.67  Although HIV- 
seropositive patients with oral candidiasis have a significant decrease in oral epithelial cell 
mediated growth inhibition of C. albicans in vitro compared to those without oral candidiasis, 
there is no difference in epithelial cell activity between HIV-seronegative and HIV- 
seropositive subjects without candidiasis.54 
 
Despite being infected by HIV, oral mucosal Langerhan’s cells are challenged to perform 
important tasks which include the uptake of Candida antigens in the mucosa and their 
presentation to CD4 T cells in draining lymph nodes.28  Multiple defects of oral Langerhan’s 
cells probably contribute to a progressive loss of protective acquired cell mediated immune 
responses to C. albicans antigens in HIV infection.28  Numbers of both oral and oesophageal 
Langerhan’s cells are depleted in HIV infection.68  It is uncertain whether decreased dendritic 
cell (DC) populations result from cytopathic changes caused by productive HIV infection, 
altered cytotoxic T-cell responses resulting in lysis of targeted DCs, migration to lymph 
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nodes where active viral replication occurs, or down-regulation of DC surface markers69.  
Increased expression of CD40 and CD86 co-stimulatory molecules has however been 
observed in blood DCs from HIV-seropositive patients.28  
 
Progressive diminution of CD8 T cells in HIV infection results from apoptosis mediated by 
macrophages through interaction of HIV gp120 with the chemokine receptor CXCR4.70  
Despite progressive diminution in absolute numbers, the remainingCD8 T cells successfully 
accumulate in the basal epithelial layer of the oral mucosa in HIV-seropositive patients with 
oral candidiasis, demonstrating that these cells can be actively recruited to the mucosa in 
response to candidiasis.28,70  
 
CD4 T cell numbers are markedly reduced in oral mucosae of HIV-seropositive patients with 
or without oral candidiasis.28  C. albicans specific peripheral CD4 T cells are depleted with 
HIV disease progression and concurrent oral candidiasis,71 but these findings have not yet 
been demonstrated for CD4 T cells isolated from cervical lymph nodes draining the oral 
mucosal surface.28  HIV-seropositive patients have a Th2 cytokine profile in saliva consistent 
with the well documented switch from Th1 to Th2 in HIV infection, which correlates with a 
loss of lymphocyte proliferation in response to Candida antigens.72   
 
NK cells are cytotoxic in vitro to certain tumor cell lines and to virally infected cells and have 
direct antimicrobial activity against Cryptococcus neoformans but little or no effect against 
C. albicans pseudohyphae in vitro.73 
 
Recruitment of phagocytes to the oral epithelium has not been demonstrated to be altered by 
HIV infection.28  Their anti-Candidal attributes could be impaired either directly by HIV 
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infection or by altered stimulation by cytokines.28  In several investigations yielding 
conflicting results, phagocytosis of C. albicans by blood monocyte derived macrophages 
from HIV-seropositive patients has been found to be either normal or reduced.74 
 
Oral keratinocytes are of importance in the pathogenesis of candidiasis since they constitute a 
physical barrier after C. albicans adheres to the oral epithelial surface.28  Oral keratinocytes 
also function as fixed immunocytes and are capable of producing a number of soluble factors, 
and express receptors that are involved in up or down regulation of immune responses.28 
Furthermore oral keratinocytes produce several growth factors including basic fibroblast 
growth factor, platelet-derived growth factors, transforming growth factors and tumour 
necrosis factor-alpha (TNF-α).75 Keratinocytes also produce several cytokines including 
interleukin (IL)-1, IL-3, IL-6, IL-7, IL-8, IL-10, IL-12, IL-15,IL-18, and IL-20, and a number 
of colony stimulating factors such as GM-CSF,G-CSF, and M-CSF .75  mRNA expression of 
IL-1γ, IL-1, IL-8, GM-CSF, and TNF-α is up regulated in experimental cutaneous C. 
albicans infection with reconstituted human epidermis,  demonstrating that Candida albicans 
induces a rapid cytokine response by host keratinocytes.75  C. albicans also triggers the 
production of IL-1γ and TNF-α, as well as GM-CSF, by primary oral epithelial cells and oral 
epithelial cell lines in vitro.75  The anti-Candidal activity of PMNs from healthy subjects and 
HIV-seropositive patients is impaired by the Th2 cytokines IL-4 and IL-10, suggesting a role 
in mediating a greater predisposition to oral candidiasis in HIV infection.28 
 
In conclusion, it is not known which of the many factors reviewed above determines the 
change in nature of the Candidal organism from its yeast state to the penetrative or vegetative 
state that is characterised by pseudohyphae in association with chlamydospores.  
Chlamydospores cannot be seen on Haematoxylin and Eosin (H&E) or Periodic Acid Schiff 
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(PAS) stained sections but only under phase contrast microscopy.  Any change in innate 
immunity, acquired host immunity or Candidal virulence factors (Fig. 1) will promote 
opportunistic organisms like C. albicans to switch from a normal commensal of the oral 
mucosae to a pathogenic organism.   
 
2.3.4 Histological features of Candida infection 
The Candidal pseudohyphae usually penetrate the superficial keratinous layers of the 
epithelium perpendicular to the surface.50  The pseudohyphae are more readily identified and 
confirmed with the Periodic Acid Schiff (PAS) stain which is absorbed by the carbohydrates, 
contained in abundance by fungal cell walls; the organisms being easily identified by the 
bright magenta colour imparted by the stain.36  The pseudohyphae are approximately 2µm in 
diameter, vary in length and may show branching.  These pseudohyphae may be 
accompanied by a variable number of vegetative yeasts or chlamydospores (visible using 
phase contrast microscopy), and often by intraepithelial neutrophilic abscesses (Munro 
abscesses).36 The histological pattern may vary slightly depending on the clinical form of oral 
candidiasis.36  Common features include an increased thickness of parakeratin on the surface 
of the lesion in conjunction with elongation of the epithelial rete ridges.36  Typically, a 
chronic inflammatory cell infiltrate can be seen in the connective tissue immediately 
subjacent to the infected epithelium and small collections of neutrophilic microabscesses 
(Munro abscesses) are often identified in the parakeratin layer with the organisms present in 
the superficial spinous layer.36  Candida pseudohyphae are embedded in the parakeratin layer 
and rarely penetrate into the viable cell layers of the epithelium unless the patient is severely 
immune compromised.36 
 
 
23 
 
2.3.5 Diagnosis and treatment of oral candidiasis 
The introduction in 1996 of HAART including protease inhibitors dramatically reduced the 
prevalence of oral candidiasis and oesophageal candidiasis in HIV infected patients.7  It has 
been documented that over an average period of 12 months following antiretroviral treatment 
including a protease inhibitor there were significant decreases in the prevalence of oral 
candidiasis, the number of relapses of oral candidiasis, the rate of asymptomatic oral carriage 
of C. albicans, and overall oral Candida burdens.28  A comparable decline in the incidence of 
oesophageal candidiasis has been observed in HIV infected children since the introduction of 
HAART.28 
 
Some patients carry large numbers of yeasts that are resistant to several antifungal treatment 
regimens and do not respond to treatment.33  Yeast counts decline during treatment but are 
restored to the original level once therapy is discontinued.  Resistance to antifungal agents 
which may be acquired or intrinsic has been reported in C. krusei and C. glabrata with C. 
krusei being universally resistant to fluconazole.33  For this reason, all oral lesions with a 
presumptive diagnosis of candidiasis should be subjected to microscopy and culture.33  
Isolated cultures should be identified to species level, antifungal sensitivity should be 
determined and primary resistance should be kept in mind during treatment.33  Typing and 
sub-typing of yeasts are probably not critical to the clinical management of candidiasis 
caused by Candida albicans and non-albicans strains, including C. dubliniensis, because 
these are responsive to antifungal therapy.  C. glabrata is probably the only exception.27,33,39  
The presence of oral thrush in infants younger than 6 months of age is associated with an 
increased postnatal transmission risk of HIV infection.33  Thus, perinatal anti-retroviral 
therapy should be combined with the treatment of oral thrush to prevent the postnatal 
acquisition of HIV.27,33,39  
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CHAPTER 3 
 
3.0 OBJECTIVES AND AIMS 
 
The objective of the study was to determine the frequency and morphology of Candidal 
secondary infection of the surface epithelium of oral HIV-KS lesions. 
 
More specifically the study aimed to determine: 
a. the demographics of the patients showing oral HIV-KS lesions with secondary  
C.albicans infection in the surface epithelium  
b. the frequency of biopsied oral HIV-KS secondarily infected with Candida and the 
density and depth of the secondary Candidal infection  
c. the histomorphology of Candidal pseudohyphal invasion of the oral epithelium and 
the cellular reactions that occur 
d. correlation of the presence, intensity and depth of invasion of C. albicans with CD4 T 
cell counts at the time of biopsy 
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CHAPTER 4 
 
4.0 MATERIALS AND METHODS 
 
4.1 Biopsy material and data collection  
Oral lesions of KS are routinely biopsied in the course of diagnosis and the slides and wax 
blocks are stored in the Division of Oral Pathology.  All cases diagnosed as oral KS were 
retrieved from the departmental archives for the period 2003 to 2007.  All of the tissue 
specimens were originally fixed in 10% neutral buffered formalin (18-48 hours) and routinely 
processed and embedded in paraffin wax.  Data regarding the patient’s age, sex, race, site of 
the lesion, HIV status and CD4 count were obtained from the clinical information recorded 
on the histopathology reports and from the patients computerised hospital records.  This was 
done following ethics approval (M00/08/29; M08.03.25).  Each case was given a study 
number in order to maintain complete patient anonymity.   
 
4.2 Study sample 
One hundred and thirty three cases which had been histologically diagnosed as oral KS 
during the study period 2003 to 2007 including the glass slides and wax blocks were retrieved 
from the departmental archives.  Twelve cases were excluded as the available material was 
inadequate for histopathological assessment.  The age, gender, site, HIV status and CD4 T 
cell count were recorded for all cases where available.  The 121 cases included in the study 
were then divided into two groups based on the HIV status of the patient.  The first group was 
the HIV-seropositive group which consisted of 32 cases.  In the second group of 89 cases, no 
information was available on the HIV status of the patient hence these cases were regarded as 
HIV status unknown and not analysed any further.  For the seropositive group new 4µ 
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sections were cut and stained with the Periodic Acid Schiff (PAS) technique and 
Haematoxylin and Eosin (H&E).  
  
4.3 Histological analysis 
The H&E stained sections were reviewed and the diagnosis confirmed by the investigator in 
conjunction with a specialist pathologist using a double headed Nikon Eclipse 80i 
microscope.  The PAS stained sections were examined histologically using conventional light 
microscopy and the following parameters were recorded: 
a. presence or absence of secondary Candidal infection in the surface epithelium or 
pyogenic membrane (a layer of non-autolysed inflammatory cells lining an epithelial 
surface or an abscess cavity) of the oral HIV-KS lesion. 
b. specific site of infection: 
epithelium only, epithelium and pyogenic membrane, epithelium and connective tissue or 
pyogenic membrane only 
c. whether only one locus or many loci of Candidal infection could be found in the biopsy 
specimen 
d. intensity of the Candida infection at each locus which was subjectively assessed as being 
mild, moderate or severe based on the number of pseudohyphae and yeasts 
e. depth of Candida invasion/penetration graded as being present in: 
superficial parakeratin only, parakeratin and reaching the spinous layer, parakeratin and 
penetration into spinous layer reaching the lamina propria and involvement of the 
pyogenic membrane in ulcerated cases 
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Fig. 2    Histological section of parakeratinised oral epithelium showing from most  
superficial to deep: the superficial keratinised layer, the darker staining granular cell 
layer, the prickle/spinous cell layer, the basal cell layer and the underlying lamina 
propria. 
f. presence of pseudohyphae only or pseudohyphae with yeasts 
g. association with neutrophilic microabscesses (Munro abscesses) in the epithelium 
h. presence of epithelial hyperplasia or pseudoepitheliomatous hyperplasia 
i. presence and type of inflammatory cells in the lamina propria 
  
4.4 Data analysis 
The clinical data obtained will be presented in table and graphic format.  The histological 
data is descriptive in nature and could not be standardised or statistically verified.  It was 
evaluated subjectively and will be presented as a series of histophotomicrographs without 
statistical comparison.  Tests for statistical significance were deemed not to be necessary as 
this is primarily a histomorphological study.   
 
4.5 Ethical considerations  
Ethics clearance (M08.03.25) [Addendum] was granted by the Human Research Ethics 
Committee (Medical) of the University of the Witwatersrand to view patient hospital files in 
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order to confirm the HIV status of the patient, the CD4 count and the viral load.  
Furthermore, the ethics code M00/08/29 used for this research project is a code granting 
permission for the use of archival tissue, obtained from human subjects, in histological or 
immunohistochemical research and allocated to the Division of Oral Pathology, Department 
of Anatomical Pathology.    
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CHAPTER 5 
 
5.0 RESULTS 
 
5.1 Initial sample (oral KS) 
The initial study sample consisted of a total of 121 cases of oral KS.  Patients in this initial 
sample ranged in age from 7 to 63 years (mean 35; median 35). The mean age for males and 
females was 36.71 years and 36.07 respectively. Most cases occurred in patients in the fourth 
decade. (Table 1) The male to female ratio of the patients with oral KS was 1:1.57 (47 males: 
74 females).(Table 1)  Virtually all of the patients in the initial sample of 121 cases were 
black with only 2 cases (2%) occurring in white patients.(Table 1)  The two white patients 
were in their fourth decade of life.(Table 1)  Forty four cases (36.36%) occurred in the palate 
followed by the gingiva in 24 cases (19.83%), tongue (22 cases; 18.18%), buccal mucosae (7 
cases; 5.78%), labial mucosa (4 cases; 3.30%), retromolar area (3 cases; 2.47%) and 2 cases 
(1.65%) in the floor of the mouth.  In 15 cases (12.39%), more than one area of the mouth 
was simultaneously affected. (Table 2)  Patient records did not indicate whether patients in 
this group were receiving HAART or not.  Dental records were also not available to confirm 
whether any of the patients in this group wore dentures or not.  
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Table 1. Age, gender and race distribution pattern in the initial sample of 121 cases of oral KS 
Decade Total   Female Male  Black  White 
0-9      1       1     0      1      0 
10-19      2        2     0      2      0 
20-29    32     27     5    32      0 
30-39    60     34   26    58      2 
40-49    16      5   11    16      0 
50-59      6      2    4      6      0 
60-69      4      3    1      4      0 
________________________________________________________________   
121   74             47  119      2 
 
 
 
Table 2. Site distribution pattern of the initial 121 cases of oral KS 
Site     n=Cases %=n/121    Male       Female 
Palate        44  36.36      19    25 
Gingiva         24   19.83       9    15 
Tongue       22  18.18       9    13 
Labial mucosa        4    3.30       1     3 
Floor of mouth          2    1.65       0     2 
Retromolar area          3    2.47       1     2 
Buccal mucosae          7    5.78       2     5 
More than one concurrent site    15               12.39       6     9 
________________________________________________________________________ 
                  121  100     47                  74 
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5.2 Study sample (HIV-seropositive patients with oral HIV-KS) 
Only 32 cases of the initial sample of 121 cases (26%) were confirmed to be HIV- 
seropositive.  In the remaining 89 cases (74%) the HIV status could not be confirmed from 
the available records.  These cases were then excluded from further analysis.   
 
Only 13 cases (40.65%) showed secondary Candida infection in the form of PAS positive 
pseudohyphae and yeast cells in the surface epithelium or pyogenic membrane. 
 
Nineteen cases (59.37%) in the HIV seropositive sample showed no evidence of Candidal 
organisms in the surface epithelium or the pyogenic membrane of oral HIV-KS lesions. 
 
5.3 Age, gender and site distribution  
5.3.1 32 HIV-seropositive cases of oral HIV-KS  
The ages ranged from 20 to 63 years (mean 41.5; median 41.5).  The mean age for males and 
females in this group was 45.5 years and 41.5 years respectively (Table 3).  Most cases 
occurred in the fourth decade and the group consisted of 12 males and 20 females. (Table 3; 
Fig. 3)The ages of the males was not statistically different from that of the females (P>0.5).  
The male to female ratio was 1:1.66 (12 males:20 females).(Table 3) 
 
The site found to be most affected was the palate (12 cases; 37.5%) followed by the tongue 
(10 cases; 31.25).(Table 3; Fig. 5) 
 
5.3.2 13 HIV-seropositive cases of oral HIV-KS secondarily infected with Candida 
The ages in this group ranged from 21 to 63 years with a mean age of 42 years and a median 
age of 42 years.  The mean age for males and females was 45.5 years and 42 years 
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respectively (Table 3).  Most cases occurred in the fourth and third decades.(Table 3; Fig. 4)  
6 cases (46.15%) occurred in males and 7 cases (53.84%) in females (male:female ratio of 
1:1.16).(Table 3; Fig. 4) 
 
The site found to be most affected in this group was the tongue (6 cases; 46.15%) followed 
by the palate in 4 cases (30.76%).(Table 3; Fig. 6)   
 
5.3.3 19 HIV-seropositive cases of oral HIV-KS not secondarily infected with Candida 
The age range in this group was from 20 to 63 years (mean 41.5; median 41.5).  The mean 
age for males and females was 49.5 years and 40.5 years respectively.(Table 3)  Most of 
these cases occurred in patients in the fourth decade followed by the third, fifth decades and 
seventh decades in both the males and the females. (Table 3) The male to female ratio was 
1:2.16. (Table 3) 
 
The site most commonly affected in this group was the palate in 42.10 % of cases (8 cases) 
followed by the tongue in 4 cases (10.52%). (Table 3) 
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Table 3. Table showing comparative demographic results in the HIV-seropositive group of 32 cases  
regardless of secondary Candidal infection, 19 cases of oral HIV-KS and in 13 cases of oral HIV-
KS secondarily infected with Candida    
 
 
HIV-KS  
n=32 
HIV-KS and secondary 
Candidal infection n=13 
HIV-KS  without Candida 
n=19 
 Male Female Male Female Male Female 
Age & Gender 
   Mean         
   Mean (T) 
   Median (T) 
        0 - 9yrs 
      10-19yrs 
      20-29yrs 
      30-39yrs 
      40-49yrs 
      50-59yrs 
      60-69yrs 
   Total 
    
M:F ratio 
 
45.5 
   41.5             
41.5 
0 
0 
1 
5 
2 
3 
1 
12 (37.5%) 
 
1:1.66 
 
41.5 
 
 
0 
0 
9 
7 
2 
0 
2 
20 (62.5%) 
 
 
45.5 
42 
42 
0 
0 
1 
3 
0 
2 
0 
6 (46.15%) 
   
1:1.16 
 
42 
 
 
0 
0 
3 
1 
2 
0 
1 
7 (53.84%) 
 
49.5 
41.5 
41.5 
0 
0 
0 
2 
2 
1 
1 
6 (31.57%) 
 
1:2.16 
 
40.5 
 
 
0 
0 
6 
6 
0 
0 
1 
13 (68.42%) 
 
Race B 
11 
W 
1 
B 
20 
W 
0 
B 
6 
W 
0 
B 
7 
W 
0 
B 
5 
W 
1 
B 
13 
W 
0 
Site 
Palate 
Tongue 
Gingiva 
Labial mucosa 
Floor of mouth 
Retromolar 
area 
 
5 
4 
1 
0 
0 
 
0 
 
7 
6 
2 
1 
1 
 
1 
 
3 
2 
0 
0 
0 
 
0 
 
1 
4 
1 
0 
1 
 
0 
 
2 
2 
1 
0 
0 
 
0 
 
6 
2 
1 
1 
0 
 
1 
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 Fig. 3  Histogram showing the peak 
 
 
 
 
 
Fig. 4  Histogram showing the peak 
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 derived HIV-KS lesions as the most commonly affected site in 
-KS lesions as the most common site secondarily 
-seropositive patients (n=13)  
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32 HIV- 
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5.4 Race distribution in the HIV-seropositive sample of 32 cases of oral HIV-KS  
The majority of patients in this sample were black except for one white male in his fourth 
decade of life who did not present with secondary Candidal infection.(Table 3)  
   
 
5.5 Histomorphology 
The histomorphology of oral mucosal HIV-KS is well described and the lesions are easily 
recognisable.  The lesional tissue in all cases of oral HIV-KS lesions showed a nodular 
growth pattern with fascicles of uniform spindle cells showing slit-like vascular spaces 
containing extravasated red blood cells and eosinophilic hyaline globules.  Numerous mitotic 
figures were also present.(Fig. 7) 
 
The Candida organisms were readily identified microscopically with the PAS stain which 
imparted a bright magenta colour to the organism.(Fig. 8)  The non-septate pseudohyphae 
varied in length and exhibited simple branching patterns in some instances.(Fig. 8 and Fig. 
10)  These pseudohyphae were accompanied by a variable number of yeast cells in the 
majority of cases (56.25%).  The Candida positive cases were sometimes characterised by a 
thick layer of parakeratin and hyperplastic elongated rete ridges of the surface epithelium 
compared to the non-infected cases.(Fig. 9) 
 
Of the 13 cases which were positive for Candida, 6 cases (46.15%) showed pseudohyphae in 
the parakeratin only (Fig. 10 and Fig. 11), 1 cases (7.69%) showed pseudohyphae in the 
pyogenic membrane and the parakeratin simultaneously (Fig. 8), 1 case (7.69%) showed the 
penetration of the Candidal organisms into the superficial layers of the epithelium and in 2 
cases (15.38%) organisms were found deep in the stratum spinosum.(Fig. 12)  In 2 cases 
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(15.38%) organisms could only be found in the necrotic slough.(Fig. 13)  A single case of 
severe Candida colonisation showed pseudohyphae to have penetrated the lamina propria as 
well as the HIV-KS lesional tissue.(Fig. 15)   
 
The severity of the secondary Candidal infection (Figs. 16 and 17) was found to be severe in 
6 cases (46.15%), moderate in 3 cases (23.07%) and mild in 4 cases (30.76%).  In the mildly 
infected cases only single, isolated organisms could be detected.  The grading of the severity 
of infection was subjective.  The organisms were usually embedded in the superficial 
parakeratin layer which otherwise showed no significant changes.(Fig. 8)  The moderately 
infected cases showed larger numbers of Candida pseudohyphae and yeast cells.  The 
parakeratin layer was thicker with desquamation and the organisms were present mainly in 
the desquamated keratin but also in and amongst the superficial parakeratin layers.(Fig. 11)  
The severely infected cases showed matted colonies of pseudohyphae and yeast cells in both 
the desquamated keratin and in the parakeratin layer (Fig. 16) sometimes reaching into the 
stratum spinosum.  The yeast cells always remained on the surface.(Fig. 16)  
 
Neutrophilic microabscesses (Munro abscesses) were found located in the superficial layers 
of parakeratin (Figs.17 and 21) in 7 cases (53.84%) but in just under half of the cases 
(46.15%) no organisms were found in close association to the microabscesses.(Fig. 19)  
Conversely in over half of the cases (53.84%) pseudohyphae were found in the epithelium 
but not in close association to the microabscesses.(Fig. 18)  
 
Inflammatory cells were frequently present beneath the Candida infected areas in the lamina 
propria.(Fig. 15)  The infiltrate which was usually mixed in nature was severe in only 1 case 
(7.69%), moderate in 3 case (23.07%) and mild in 7 cases (53.84%) cases (Fig. 14).  2 cases 
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(15.38%) showed no evidence of inflammation.(Fig. 20)  The grading of the severity of 
inflammation was also subjective.  Acute inflammation was characterised by a predominance 
of neutrophils and chronic inflammation was characterised by few neutrophils, mainly 
lymphocytes, histiocytes and plasma cells.    
 
Epithelial hyperplasia (Fig. 9) was noted in 8 cases (61.53%) of the infected cases usually 
when the infection was severe.  Pseudoepitheliomatous hyperplasia occurred in only 1 case 
(7.69%) of severe infection.(Fig.22) 
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          Fig. 7  Oral HIV-KS section. Note the hyperkeratotic oral epithelium with an underlying  
                      spindle cell component and prominent vascularity (H&E, original  
                      magnification x 20) 
 
 
 
Fig. 8 High power view showing the preference of Candidal pseudohyphae and  
budding yeast cells for the desquamating surface keratin.  Pseudohyphae   
do not penetrate the stratum spinosum (PAS, original magnification x 40) 
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Fig. 9 Low power view of a telangiectatic variant of oral HIV-KS depicting  
numerous dilated telangiectatic spaces in the lesional tissue. The  
parakeratin is heavily infiltrated by Candidal pseudohyphae. Surface  
epithelial hyperplasia and pseudoepitheliomatous hyperplasia is also  
evident (PAS, original magnification x10) 
 
Fig. 10 High power view showing that although the infestation of yeast cells  
and pseudohyphae is heavy at the junction of the parakeratin layer and  
the stratum spinosum, penetration beyond the parakeratin does not occur  
(PAS, original magnification x 40) 
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Fig. 11 High power view of Candidal infection restricted to the  
parakeratin layer (PAS, original magnification x 40) 
 
 
 
Fig. 12 High power view showing a moderate infiltration of pseudohyphae. Most  
of the pseudohyphae penetrate the superficial parakeratin layer and a single  
pseudohyphus has penetrated the superficial spinous layer (PAS, original  
magnification  x 40) 
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Fig. 13 An unusual case of organisms growing in the pyogenic membrane  
(PAS, original magnification x 20) 
 
 
 
 
Fig. 14 High power view showing the fibrinous nature of the pyogenic  
membrane (H&E, original magnification  x 20) 
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Fig. 15 High power view showing the most severe case of deep pseudohyphal  
penetration into the connective and ulcerated lesional tissue 
(arrowed). An inflammatory infiltrate is present in the lamina  
propria (PAS, original magnification x 40) 
 
 
 
Fig. 16 High power view showing a severe and heavy infection on the  
surface by yeast cells, and by pseudohyphae which have a higher  
penetrative capacity (PAS, original magnification x 40) 
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Fig. 17 High power view showing a moderate number of pseudohyphae,  
associated microabscesses and a bright pink band of glycogen (PAS,  
original magnification x 40) 
 
 
 
 
Fig. 18 High power view showing exocytosis of neutrophils from blood  
vessels forming Munro abscesses which are associated with the  
presence of pseudohyphae (PAS, original magnification x 40) 
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Fig. 19 High power view showing neutrophilic exocytosis from blood  
vessels and microabscesses without associated pseudohyphae. (PAS,  
original magnification x 40) 
 
 
 
 
Fig. 20 High power view showing pseudohyphae without an associated  
inflammatory cell exocytosis (PAS, original magnification x 40) 
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Fig. 21 High power view showing organisms in the parakeratin layer and  
the presence of an inflammatory exocytosis (PAS, original  
magnification x 40) 
 
 
 
Fig. 22 Low power view showing pseudoepitheliomatous hyperplasia of the  
surface epithelium covering the HIV-KS lesional tissue area (PAS,  
original magnification x 10) 
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5.6 Correlation of CD4 T cell count with Candidal presence, intensity of infection  
and depth of invasion 
The CD4 T cell count was known in 31 of the 32 cases of the oral HIV-KS group.(Fig. 23) 
Patient records did not indicate whether patients in this group were receiving HAART or not.  
All of the 31 patients whose CD4 T cell counts were recorded were HIV- seropositive.  If the 
CD4 T cell count in the 13 cases of oral HIV-KS secondarily infected with Candida is plotted 
against the presence, intensity and depth of penetration of the fungal organism, it appears as 
if an inverse relationship exists between the CD4 T cell count and the intensity and depth of  
penetration.(Table 4)  Cases with low CD4 T cell counts show a deeper penetration of 
Candidal pseudohyphae.(Table 4; Fig 24)  This correlation must be regarded as pure 
speculation due to too few CD4 T cell records being available.  In the group of 19 cases of 
oral HIV-KS where there was no Candidal growth, the CD4 T cell counts are equally as low 
as the CD4 T cell counts in the 13 cases of oral HIV-KS secondarily infected with Candida, 
with 9 cases recording counts lower than 100 cells/mm3 .(Fig. 25)  We therefore speculate 
that CD4 T cell count is not a determinant in Candidal secondary infection of the surface 
epithelium oral HIV-KS lesions but this correlation remains to be confirmed in a larger study 
sample.     
 
 
 
 
 
 
 
 
                Fig. 23 Histogram showing CD
Fig. 24 Histogram showing CD
secondarily infected with 
                Fig. 25 Histogram showing 
without secondary 
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 Table 4. Table showing histological features of the biopsy specimen/s at the time of haematological analysis  
CD4 T cell Histological Features 
count 
___________________________________________________________________________                         
599 – 500: Candida present in the epithelium in all cases, multiple loci of infection, mild 
infection in all cases, mild epithelial hyperplasia, presence of pseudohyphae 
and yeast cells, presence of an acute to mild chronic inflammatory infiltrate  
 
499 – 400: No correlating data available for this subset 
 
399 – 300: No correlating data available for this subset 
 
299 – 200: Candida present in the epithelium in all cases, multiple loci of infection, mild 
infection in all cases, moderate epithelial hyperplasia, presence of 
pseudohyphae and yeast cells, presence of an acute to a mild chronic 
inflammatory infiltrate.  One case presented with an infection that was graded 
as severe.   
 
199 – 100: No data available for this subset 
 
99 – 0:  In 2 cases involvement of the spinous layer, multiple loci of infection, 
moderate epithelial hyperplasia, presence of pseudohyphae and yeast cells, 
presence of a mild chronic infiltrate, grading of infection which ranged 
between moderate (1 case) and severe infection (1 case).  
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CHAPTER 6 
 
6.0 DISCUSSION 
 
The frequency of HIV/AIDS has currently reached epidemic proportions in South Africa.13  
As could be expected the frequency of KS has also increased dramatically.13  In 21% of HIV- 
seropositive people who develop KS, the initial presentation will be in the mouth, while in 
71.5% of HIV-seropositive people who develop KS, the mouth will be affected at some time 
in the course of the disease.76   The number of cases of oral KS seen in our department’s 
biopsy service increased from 84 cases for the period 1973 to 2002,77 to 133 new cases 
during the period 2003 to 2007.   
 
6.1 HIV testing in South Africa 
In South Africa HIV testing is not compulsory nor is AIDS a notifiable disease.78  In fact 
performing an HIV test without informed consent or pre-testing and post-testing counselling 
is a criminal offence since the patients constitutional rights will have been violated.78  
Therefore, it was to be expected that hospital and pathology records would be lacking in 
essential information such as HIV status, CD4 T cell counts and viral loads making 
retrospective studies of this nature difficult.  Thus in this study a potentially large initial study 
sample of 121 cases was depleted to 32 cases because we were unable to confirm the HIV 
status of the 89 patients. 
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6.2 Oral HIV-KS and candidiasis  
The results of this study showed a secondary Candidal infection rate of oral HIV-KS lesions 
of only 40.62%.  Prior to this study an anecdotal and subjective view held by 
histopathologists was that the secondary Candidal infection rate of HIV-KS lesions would be 
very high.  There are unfortunately no comparable studies in which the infection rate or the 
histomorphology of Candidal secondary infection of oral HIV-KS lesions have been studied 
to compare our results with.   
 
In considering the possible reasons for the relatively low rate of infection it must be realised 
that the surface epithelium covering a lesion of oral KS or oral HIV-KS might very well be 
unique and might not be comparable to other HIV related lesions or indeed even to normal 
epithelium in an HIV-seropositive patient.  The presence of an oral KS or oral HIV-KS lesion 
may well influence the surface epithelium by induction from a range of cytokines, 
prostaglandins and genetic influences, all of which influence the response of the oral 
epithelium to penetration by C. albicans.  Oral KS or oral HIV-KS tumour cells may create a 
unique micro-milieu that cannot be reproduced in other situations.  One cannot infer that the 
mechanism by which secondary Candidal infection of oral HIV-KS occurs is necessarily the 
same as that of primary penetration of Candida in HIV-seropositive and HIV-seronegative 
patients or in other situations of Candidal infection in the mouth and more importantly in 
other mucosal sites.  For example oropharyngeal candidiasis (OPC) occurs very commonly in 
the oropharyngeal mucosa of HIV-seropositive women but is rarely seen in the vaginal 
mucosa of the same cohort.28   
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Surveys of the frequency of all forms of oral candidiasis in HIV-seropositive patients have 
shown that Candidal infection rates vary from a low of 38% in Tanzania to a high of 94% in 
Zaire.30,79  In South Africa Candidal infection rates ranging from 37.8% to 63% have been 
reported.30,79  The rate of secondary Candidal infection of oral HIV-KS lesions of 40.62% in 
our study seems to be consistent with these reported figures. 
 
6.3 Oral HIV-KS 
6.3.1 Oral HIV-KS and gender 
Although KS has traditionally been regarded as a male predominant disease, in South Africa 
this lesion has shown an ever greater involvement of women in very recent times.80  
According to the South African National Cancer Registry (1992-1996) the incidence of KS 
has doubled in men and has increased about seven-fold in women resulting in the decline of 
M:F ratio from 7:1 in 1988 to 2:1 in 2001.13  Somdyala et al.14 also reported a higher 
incidence of KS in males (1.6 per 100 000) than females (0.3 per 100 000) whilst  
Mosam et al.81 reported that HIV-KS in black South Africans has an equal gender 
predilection.  In England and Wales the male to female ratio of KS was reported to be 2:1.82 
 
In a previous study from our department in which 81 cases of oral KS were accessioned 
during the period 1997-2003 the male to female ratio was reported to be 1.31:1.77  At that 
time we suggested that the male predominance might have been accounted for by differences 
in the mode of transmission of HIV being predominantly heterosexual in the South African 
context.77 
 
The results of this study showed a marked female predominance in all sample groups 
analysed (Table 1; Table 3) which is consistent with the dramatic increase in HIV infection of 
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women in this population.83  In all age groups in Africa there are more females infected with 
HIV than males which may explain the reversal of the male to female ratio in favour of 
females.83  This gender imbalance of HIV infected persons in Africa is most marked amongst 
the youth where in the 15-24 age group there are 4 HIV infected females to every male.83  
 
The decline in the male to female ratio to 1.1:1 in Uganda in cases of HIV-KS may be 
attributed to detection bias during earlier periods and an increased awareness of HIV-KS in 
women.82  The decrease in the male to female ratio of HIV-KS in Africa being due to 
HAART is unlikely as the decline occurred in Uganda before HAART becoming available in 
1998 and the incidence of HIV-KS has not changed significantly in the 15-49 year age group 
since the introduction of HAART.82     
 
6.3.2 Oral HIV-KS and age 
HIV-KS has been reported as occurring in all age groups even in patients as young as 2 years 
old with the majority of patients being in their third and fourth decade of life.77  Our study 
has similarly reported a predominance of patients in their third and fourth decades with no 
difference in ages between those HIV-KS patients who were secondarily infected with 
Candida and those who were not.  
 
Lager et al.77 also reported that the mean age of the patients with oral KS in his sample was 
34.7 years which is consistent with our findings of a mean age for oral KS of 35 years.  Our 
study reported a mean age of 41.5 years for subjects with HIV-KS (32 cases) regardless of 
secondary infection (Table 3).  The mean age for males and females in the HIV-KS group of 
32 cases was 45.5 years and 41.5 years respectively confirming Mosam et al’s.81 findings that 
females afflicted by HIV-KS were younger than males (Table 3).    
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6.3.3 Oral HIV-KS and site 
Oral KS most frequently affects the palate, gingiva and the dorsum of the tongue.77  Our 
study has demonstrated a similar predilection of oral HIV-KS for the palate followed by the 
tongue in the study sample of 32 HIV seropositive patients regardless of secondary Candidal 
infection.  This finding was similar in the 19 cases of oral HIV-KS without Candidal 
secondary infection,  however in the 13 cases of oral HIV-KS secondarily infected with 
Candida, the site found to be most commonly affected was the tongue followed by the palate.  
 
6.3.4 Oral HIV-KS and dendritic cells 
In considering the reasons why only 40.62% of cases are secondarily infected with Candida, 
an associated study in our department has shown that there is a dramatic decrease in the 
numbers of intraepithelial dendritic cells in oral lesions of HIV-KS and that this decrease was 
most marked in the cases which were secondarily infected with C. albicans.  Dendritic cells 
appear to play a significant role in oral HIV-KS tumourogenesis due to either qualitative or 
quantitative changes in these cells.84 
 
Dendritic cells are targets of HIV infection.  It is uncertain whether decreased dendritic cell 
populations result from cytopathic changes caused by productive HIV infection, altered 
cytotoxic T-cell responses resulting in lysis of targeted dendritic cells, phenotypic change 
with a decrease in HLA-DR phenotype, migration to lymph nodes where active viral 
replication occurs, or down or up-regulation of dendritic cell surface markers.69,85  We can 
only speculate that the more severe and deeper Candidal secondary infections is owing to the 
decreased numbers of dendritic cells rather than to the inherent penetrative capacity of the 
organisms or its ability to grow under anaerobic conditions.  Two kidney transplant patients 
are reported to have developed KS simultaneously with a reduction in dendritic cells after 
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being treated with cyclosporine.86  Reduction of cyclosporine led to a return of normal levels 
of dendritic cells and complete regression of KS.86 
 
6.4 CD4 T cell counts 
It is well known that oral HIV-KS may develop at any stage of HIV infection and that it 
undoubtedly occurs more frequently when the CD4 T cell count falls below 200 
cells/mm3.9,12,22   This fact was well illustrated in our study where analysis of the CD4 T cell 
counts confirmed that most cases of oral HIV-KS occurred at CD4 T cell counts below 100 
cells/mm3 but there were some patients whose CD4 T cell counts were in the order of 600 
cells/mm3.  Of greater interest in our study was the fact that there appeared to be no 
difference in CD4 T cell counts between those cases which were and those which were not 
secondarily infected with C. albicans.  The inevitable conclusion to be drawn from this result 
is that CD4 T cells are not a determining factor in the pathogenesis of secondary candidiasis 
in oral HIV-KS but this conclusion remains speculative due to the small sample size.  In a 
similar study, 75% of 130 cases of HIV-KS lesions were reported to have CD4 T cell counts 
of less than 200 cells/mm3 and the authors also concluded that low CD4 T cell counts were 
not a prerequisite for the development of HIV-KS.9,12,22 
 
6.5 Histopathology 
KS has a very broad histological spectrum although most cases can be readily identified as 
the lesion changes from patch to plaque and then on to a nodular growth phase.  New 
histomorphological variants are reported regularly in the literature.  A review of the various 
histological types of cutaneous KS has been provided by Grayson and Pantanowitz.84  These 
variants are important for correct histological diagnosis but may also be of prognostic 
significance.84  There are the usual variants of patch, plaque and nodular as well as the 
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variants reported in the older literature which include the anaplastic, lymphodeamotous, 
lymphangioma-like, lymphangiectatic, bullous, telangiectatic and lastly the contemporary 
variants which include the hyperkeartotic verrucous, keloidal, micro-nodular, pyogenic 
granuloma-like, ecchymotic, intravascular, glomeruloid, pigmented and myoid nodular KS.84 
 
This study made no attempt to characterise the histological variants of oral HIV-KS, but was 
restricted to the surface epithelium or pyogenic membrane and the presence of secondary  
C. albicans infection.  Histopathologists are aware of the presence of secondary infections or 
co-existing lesions in KS and HIV-KS.87  AIDS associated cases may show evidence of 
opportunistic infections such as bacillary angiomatosis, cryptococcus or cytomegalovirus 
infections but these are usually found in the lesional tissue itself.84,87 
 
We are not aware of any studies in which the frequency and morphology of secondary 
Candidal infection in oral lesions of HIV-KS have been studied and ours seems to be the first 
to establish this frequency and to describe the histomorphology.  The relatively low 
frequency of secondary Candidal infection of oral HIV-KS was indeed of interest and 
requires further investigation as does the deeper penetration of Candidal pseudohyphae into 
the epithelium, the proliferation of the pseudohyphae in the pyogenic membrane and even 
into the connective tissue.  Such growth characteristics are not usual for this organism. 
         
The results of this study have shown that less than half (40.62%) of all biopsies of oral HIV-
KS are secondarily infected with C. albicans.  The Candidal pseudohyphae are generally 
present in the surface epithelium immediately above the oral HIV-KS lesional cells. We do 
not know whether the oral HIV-KS lesions with Candida infected epithelium could be 
distinguished clinically from the cases without secondary Candidal infection as we did not 
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have the opportunity to monitor the patients.  Furthermore, we have shown that the severity 
of the infection caused by C. albicans varies considerably from single isolated pseudohyphae 
to matted colonies of fungal organisms.  The morphology of the less severe infections closely 
mimics Candidal infections seen in immunocompetent hosts whereas in the severe infections, 
the organisms in the HIV-seropositive group penetrate deeper than do those in 
immunocompetent hosts and are also more numerous.   
 
C. albicans pseudohyphae are usually restricted to the upper layers of the oral epithelium in 
candidiasis and are some distance away from lymphocytes and dendritic cells located in 
deeper layers.28  Our study has further confirmed that generally C. albicans, regardless of the 
severity of the infection, rarely reaches the lamina propria by penetrating through the 
epithelium.  In a single case of severe infection where the organism had penetrated the 
connective tissue and the KS lesional tissue it had penetrated through the necrotic ulcerated 
surface.  In fact the pseudohyphae are usually found only in the superficial layers of 
parakeratin and very seldom in the stratum spinosum.  The reasons for this are unclear but 
perhaps the more anaerobic conditions found deep in the epithelium limit the depth of 
infiltration of the organism.  It did however appear to us that in the more severe infections the 
organisms did penetrate deeper reaching the upper third of the stratum spinosum.  
 
The presence of neutrophilic permeation leading to the formation of small microabscesses 
within the superficial layers of the epithelium in C. albicans infected epithelium is well 
known to oral histopathologists.36  Very often the presence of these abscesses is an indication 
of the presence of organisms in that area but we have seen organisms in the epithelium which 
was devoid of microabscesses and we have seen the presence of microabscesses but with no 
associated organisms.  The significance of these inflammatory cells is therefore unknown. 
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Of further interest was the finding of pseudohyphae within the pyogenic membrane of the 
biopsy specimens.  This is an unusual finding and we have not previously noted this 
phenomenon.  The C. albicans organism is epitheliotrophic and depends on attachment and 
penetrative biological processes to infect host tissue.28  We do not know whether those are 
inherent in either of or both the organism and host epithelium.  Clearly invasion of the 
pyogenic membrane shows that epithelial factors are not absolutely essential to the growth of 
the organism but that under certain circumstances the organism is also capable of living in the 
fibrinopurulent exudate that forms the pyogenic membrane. 
      
Although assessment of the histology was entirely subjective, we did agree that as far as 
tissue reactions are concerned, there were no differences between the histological sections 
studied in the HIV seropositive group and the HIV seronegative group.  If we compare the 
histology of those of our oral HIV-KS cases which were secondarily infected with Candida 
from those which were not secondarily infected with Candida, the only discernable 
differences were the absence of a thick pseudomembrane of desquamated parakeratin, the 
presence of Candidal organisms and the absence of pseudoepitheliomatous hyperplasia. 
   
This study has raised many further questions regarding the pathogenesis of tissue invasion 
and penetration, the effect of HIV in these processes and the very rare ability of the organism 
to grow in non-epithelial surface tissues. 
 
6.6 Extent to which aims have been reached 
The aims of this study were to establish the frequency of secondary Candidal infection of the 
surface epithelium of oral lesions of HIV-KS and to describe the histomorphology of this 
infection and the cellular reactions that occur. We have largely succeeded in this regard. 
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6.7 Strengths and weaknesses of the study  
The main difficulty in this study stemmed from the fact that we were not able to definitively 
establish the HIV status of 89 cases.  We were therefore faced with the choice of either 
assuming that they were seropositive or eliminating them from the initial sample.  We chose 
the latter course of action thus reducing a potentially large sample to one that may be too 
small from which to draw any meaningful conclusions. 
 
6.8 Directions for future research 
Histomorphological studies very often open up new directions of research as investigators 
seek answers to explain particular morphological trends or features of disease.  So was the 
case in this study when the pathogenesis of oral candidiasis came under scrutiny, to explain 
features such as the increased intensity of Candidal infection, deeper penetration of Candidal 
pseudohyphae, the change from yeast to vegetative to pseudohyphal form and the growth of 
the organism in non-epithelial tissues such as the pyogenic membrane.      
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CHAPTER 7 
 
7.0 CONCLUSION 
 
In conclusion,  
• 40.62% of oral HIV-KS lesions were secondarily infected with Candida.  We 
expected this figure to be much higher.  One of the reasons for this is that many cases 
of oral HIV-KS are covered by a pyogenic membrane rather than by epithelium. 
• a significant finding was the striking predominance of females in the initial sample of 
oral KS lesions and the oral HIV-KS sample compared to other studies in the 
literature reporting a male predominance.  
• an unusual finding was that Candidal pseudohyphae and yeasts were very rarely  
found in the fibrinopurulent exudate overlying the oral HIV-KS lesional tissue.  
Candida is strongly epitheliotrophic and its growth in exudate is most unusual. 
• in a few cases of severe infection pseudohyphae were shown to invade beyond the 
parakeratin into the upper third of the stratum spinosum. 
• one case showed the organism penetrating into the connective tissue and oral HIV-KS 
lesional tissue. 
• inflammatory exocytosis and Munro micro-abscess formation was frequently present, 
but this did not invariably indicate proximity of the organisms.  Organisms were often 
present in the absence of inflammation in the epithelium.  
• although it appeared as if an inverse relationship existed between CD4 count and the 
the intensity and depth of infection, this data could not be confirmed. 
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• CD4 T cell count does not play a role in Candidal secondary infection of oral HIV-
KS lesions, however this conclusion must be regarded with caution because of the 
small study sample. 
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